Yale SPORE in Lung Cancer News
Combination chemotherapy has long been a mainstay of cancer treatment, although early mechanism-based therapies showed little promise. More than 50 years later, this foundational principle — in which biologic rationale is used to guide the choice of treatment combinations — is being applied to the leading cause of cancer-related deaths: lung cancer. Today, genomic profiling, targeted agents, and strategies informed by resistance mechanisms are reshaping care for epithelial growth factor receptor (EGFR)–mutated non–small-cell lung cancer (NSCLC).
- December 22, 2025
Veronica Chiang, MD, professor of neurosurgery, is currently leading several clinical trials seeking to improve treatments for brain metastases, or cancers that has spread to the brain). She recently sat down for an interview about this important work.
- December 22, 2025Source: CNN
Legendary singer songwriter Barry Manilow reveals that he's been diagnosed with lung cancer. We'll ask a lung cancer specialist what sort of treatment may lie ahead.
- December 16, 2025
Members of the Center for Breast Cancer and the Hematology Program at Yale Cancer Center and Smilow Cancer Hospital recently presented their latest groundbreaking research on two national stages. First at the annual American Society of Hematology (ASH) meeting, followed by the annual San Antonio Breast Cancer Symposium (SABCS).
- December 13, 2025
Members of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center attended the 48th annual San Antonio Breast Cancer Symposium (SABCS), from December 9-12, 2025.
- December 09, 2025
Physicians, scientists, and trainees from Yale Cancer Center and Smilow Cancer Hospital attended the 67th annual meeting of the American Society of Hematology in Orlando, FL, December 6-9, 2025 to present the latest advances in hematological research and clinical care from Yale.
- December 01, 2025
At SABCS, Yale Cancer Center experts will present groundbreaking research on hormone replacement therapy in breast cancer care, innovative treatment options for HER2-positive and hormone receptor-positive breast cancers, and the impact of patient-centered approaches to care.
- November 18, 2025
On November 17, 2025, in honor of Lung Cancer Awareness Month, members of our Center for Thoracic Cancers at Smilow Cancer Hospital and Yale Cancer Center presented a patient forum: "Progress and Hope: Sharing the Latest Advances in Lung Cancer Care." The event was held in person at 55 Park Street in New Haven, CT.
- November 13, 2025
Dr. Roy Herbst shares the progress that has been made in lung cancer care and research at Smilow Cancer Hospital and Yale Cancer Center.
- November 12, 2025
Yale School of Medicine faculty members were recognized for publishing studies that rank in the top 1% based on the number of citations they received in their field.